Formulary Update
Posted on December 4, 2018
The online formularies are updated throughout the year as changes are made. We have three formularies, one for each line of business – Commercial, Medicare Advantage and BeHealthy Partnership/Medicaid. Each formulary includes the tier assignment for each drug and any drug-specific medication management requirements, including quantity limitations, step therapy requirements and prior authorization requirements.
Most recently, the following medications have been reviewed:
| Brand Name: Andexxa | Generic Name: coagulation factor XA |
| Brand Name: Braftovi | Generic Name: encorafenib |
| Brand Name: Lucemyra | Generic Name: lofexidine |
| Brand Name: Mektovi | Generic Name: binimetinib |
| Brand Name: Norvir powder | Generic Name: ritonavir |
| Brand Name: Orkambi granules | Generic Name: lumacaftor/ivacaftor |
| Brand Name: Osmolex | Generic Name: amantadine |
| Brand Name: Palynziq | Generic Name: pegyaliase-pqpz |
| Brand Name: Signifor LAR | Generic Name: pasireotide |
| Brand Name: Tetravex | Generic Name: tetracaine |
| Brand Name: Yonsa | Generic Name: abiraterone |
No Comments
Share:
